Group, PHOSP-COVID S C & Dark, P 2023, ' Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study. ', EClinicalMedicine, vol. 57, no. 101896 . https://doi.org/10.1016/j.eclinm.2023.101896 McAuley, H J C, Evans, R A, Bolton, C E, Brightling, C E, Chalmers, J D, Docherty, A B, Elneima, O, Greenhaff, P L, Gupta, A, Harris, V C, Harrison, E M, Ho, L-P, Horsley, A, Houchen-Wolloff, L, Jolley, C J, Leavy, O C, Lone, N I, Man, W D-C, Marks, M, Parekh, D, Poinasamy, K, Quint, J K, Raman, B, Richardson, M, Saunders, R M, Sereno, M, Shikotra, A, Singapuri, A, Singh, S J, Steiner, M, Tan, A L, Wain, L V, Welch, C, Whitney, J, Witham, M D, Lord, J, Greening, N J, PHOSP-COVID Study Collaborative Group, Armour, C, Busby, J, Connolly, B, Drain, S, Grieve, D, Hart, N, Harvey, M, Heaney, L G, Hughes, J, Jones, M G, Magee, N, McArdle, A, McGarvey, L, Mills, C, Mitchell, J, Peto, T, Rowland, M, Sharma, M & Siddiqui, S 2023, ' Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study ', eClinicalMedicine, vol. 57, 101896 . https://doi.org/10.1016/j.eclinm.2023.101896
2022, ' SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination ', EBioMedicine, pp. 104402 . https://doi.org/10.1016/j.ebiom.2022.104402 Liew, F, Talwar, S, Cross, A, Willett, B J, Scott, S, Logan, N, Siggins, M K, Swieboda, D, Sidhu, J K, Efstathiou, C, Moore, S C, Davis, C, Mohamed, N, Nunag, J, King, C, Thompson, A A R, Rowland-Jones, S L, Docherty, A B, Chalmers, J D, Ho, L-P, Horsley, A, Raman, B, Poinasamy, K, Marks, M, Kon, O M, Howard, L, Wootton, D G, Dunachie, S, Quint, J K, Evans, R A, Wain, L V, Fontanella, S, de Silva, T I, Ho, A, Harrison, E, Baillie, J K, Semple, M G, Brightling, C, Thwaites, R S, Turtle, L, Openshaw, P J M, ISARIC4C Investigators, Armour, C, Carson, G, Busby, J, Connolly, B, Cooper, J, Drain, S, Grieve, D, Hart, N, Harvey, M, Heaney, L G, Hughes, J, Jones, M G, Magee, N, McArdle, A, McGarvey, L, Mills, C, Mitchell, J, Peto, T, Powell, N, Rowland, M, Sharma, M & Siddiqui, S 2023, ' SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination ', EBioMedicine, vol. 87, 104402 . https://doi.org/10.1016/j.ebiom.2022.104402 Horsley, A, Dark, P, Felton, T, et al, ISARIC4C Investigators & PHOSP-COVID Collaborative Group 2023, ' SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination ', EBioMedicine, vol. 87, 104402 . https://doi.org/10.1016/j.ebiom.2022.104402
Zheng, B, Vivaldi, G, Daines, L, Leavy, O C, Richardson, M, Elneima, O, McAuley, H J C, Shikotra, A, Singapuri, A, Sereno, M, Saunders, R M, Harris, V C, Houchen-Wolloff, L, Greening, N J, Peffer, P E, Hurst, J R, Brown, J S, Shankar-Hari, M, Echevarria, C, De Soyza, A, Harrison, E M, Docherty, A B, Lone, N I, Quint, J K, Chalmers, J D, Ho, L-P, Horsley, A, Marks, M P, Poinasamy, K, Raman, B, Heaney, L G, Wain, L V, Evans, R A, Brightling, C E & Martineau, A R & Sheikh, A 2023, ' Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls ', The Lancet Regional Health-Europe, vol. 29, 100635 . https://doi.org/10.1016/j.lanepe.2023.100635 PHOSP-COVID Study Collaborative Group 2023, ' Determinants of recovery from post-COVID-19 dyspnoea : analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls ', The Lancet Regional Health-Europe . https://doi.org/10.1016/j.lanepe.2023.100635